EP1420018 - Pyrido¬1,2-a benzimidazole derivatives useful in treating central nervous system disorders [Right-click to bookmark this link] | |||
Former [2004/21] | Pyrido[1,2-a]benzimidazole derivatives useful in treating central nervous system disorders | ||
[2007/46] | Status | The application is deemed to be withdrawn Status updated on 18.05.2007 Database last updated on 31.08.2024 | Most recent event Tooltip | 12.10.2007 | Change - German title | published on 14.11.2007 [2007/46] | Applicant(s) | For all designated states Ortho-McNeil Pharmaceutical, Inc. U.S. Route No. 202, P.O. Box 300 Raritan, NJ 08869-0602 / US | [N/P] |
Former [2004/21] | For all designated states Ortho-McNeil Pharmaceutical, Inc. U.S. Route No.202, P.O. Box 300 Raritan, NJ 08869-0602 / US | Inventor(s) | 01 /
Reitz, Allen B. 109 Greenbriar Road Lansdale, PA 19446 / US | 02 /
Jordan, Alfonzo D. 106 Victoria Lane Horsham, PA 19044 / US | 03 /
Sanfilippo, Pauline J. 7 Quimby Lane Flemington, NJ 08822 / US | 04 /
Scott, Malcolm K. 1036 Barley Way Lansdale, PA 19446 / US | 05 /
Smith, Anna V. 3138 Burks Lane Austin, TX 78732 / US | [2004/21] | Representative(s) | Mercer, Christopher Paul, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
Former [2004/21] | Mercer, Christopher Paul, et al Carpmaels & Ransford 43, Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 03078326.0 | 03.10.1997 | [2004/21] | Priority number, date | US19960027511P | 07.10.1996 Original published format: US 27511 P | [2004/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1420018 | Date: | 19.05.2004 | Language: | EN | [2004/21] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 31.03.2004 | Classification | IPC: | C07D471/04, A61K31/435 | [2004/21] | CPC: |
C07D471/04 (EP)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2004/21] | Extension states | SI | 01.11.2004 | Title | German: | Pyrido¬1,2-a benzimidazol-Derivate zur Behandlung von Erkrankungen des zentralen Nervensystems | [2007/46] | English: | Pyrido¬1,2-a benzimidazole derivatives useful in treating central nervous system disorders | [2007/46] | French: | Derives de pyrido¬1,2-a benzimidazole utiles dans le traitement des troubles du systeme nerveux central | [2007/46] |
Former [2004/21] | Pyrido[1,2-a]benzimidazol-Derivate zur Behandlung von Erkrankungen des zentralen Nervensystems | ||
Former [2004/21] | Pyrido[1,2-a]benzimidazole derivatives useful in treating central nervous system disorders | ||
Former [2004/21] | Derives de pyrido[1,2-a]benzimidazole utiles dans le traitement des troubles du systeme nerveux central | Examination procedure | 29.10.2004 | Examination requested [2004/53] | 26.04.2005 | Despatch of a communication from the examining division (Time limit: M06) | 31.10.2005 | Reply to a communication from the examining division | 14.11.2005 | Despatch of a communication from the examining division (Time limit: M04) | 21.03.2006 | Reply to a communication from the examining division | 01.08.2006 | Communication of intention to grant the patent | 12.12.2006 | Application deemed to be withdrawn, date of legal effect [2007/25] | 18.01.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2007/25] | Parent application(s) Tooltip | EP97909992.6 / EP0935598 | Fees paid | Renewal fee | 21.10.2003 | Renewal fee patent year 03 | 21.10.2003 | Renewal fee patent year 04 | 21.10.2003 | Renewal fee patent year 05 | 21.10.2003 | Renewal fee patent year 06 | 21.10.2003 | Renewal fee patent year 07 | 14.10.2004 | Renewal fee patent year 08 | 12.10.2005 | Renewal fee patent year 09 | Penalty fee | Additional fee for renewal fee | 31.10.2006 | 10   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO9404532 (MCNEILAB INC [US], et al) [A] 1-21 * claim 1; tables 1-4,6,7 *; | [A]US5521200 (HO WINSTON [US], et al) [A] 1-21* the whole document *; | [A] - MARYANOFF B E ET AL, "POTENTIAL ANXIOLYTIC AGENTS. PYRIDOLU1,2-ABENZIMIDAZOLES: A NEW STRUCTURAL CLASS OF LIGANDS FOR THE BENZODIAZEPINE BINDING SITE ON GABA-A RECEPTORS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (1995), vol. 38, ISSN 0022-2623, pages 16 - 20, XP002053732 [A] 1-21 * the whole document * DOI: http://dx.doi.org/10.1021/jm00001a005 | [A] - MARYANOFF B E ET AL, "POTENTIAL ANIOLYTIC AGENTS. 2. IMPROVEMENT OF ORAL EFFICACY FOR THEPYRIDOU1,2-ABENZIMIDAZOLE (PBI) CLASS OF GABA-A RECEPTOR MODULATORS", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (1996), vol. 6, no. 3, ISSN 0960-894X, pages 333 - 338, XP002054104 [A] 1-21 * the whole document * DOI: http://dx.doi.org/10.1016/0960-894X(96)00025-X |